[144] Amalgamated Financial Corp. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Amalgamated Financial Corp. (AMAL) reports a proposed sale of 9,217 common shares to be executed through APEX CLEARING on the Nasdaq on 08/25/2025 with an aggregate market value of $274,956. The filing shows these shares were acquired as net shares from restricted stock vesting on eight separate dates in 2025, totaling 9,217 shares. The filing lists 30,109,078 shares outstanding. No sales by the reporting person are reported in the past three months. The notice includes the standard signer representation that the seller does not possess undisclosed material adverse information. Several administrative fields such as filer CIK and full issuer address are not provided in the visible content.

Positive

• Full breakdown of vesting dates and amounts for the 9,217 shares, aiding compliance traceability
• Broker identified (APEX CLEARING) and specific execution venue (Nasdaq) clarified
• No reported sales in the past three months, which is relevant for Rule 144 volume calculations
• Aggregate market value disclosed ($274,956), giving clear monetary context

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale of vested restricted shares; small relative to outstanding stock, limited market impact.

The Form 144 discloses a planned sale of 9,217 common shares valued at $274,956, to occur through APEX CLEARING on Nasdaq. The shares originate from restricted stock vesting across eight dates in 2025, indicating these are compensatory awards being liquidated rather than open-market purchases or other transfers. Relative to the reported 30,109,078 shares outstanding, the block represents roughly 0.03% of outstanding stock, suggesting negligible dilution or market pressure. The filing contains the standard attestation about absence of undisclosed material information. Missing administrative details (e.g., filer CIK and full issuer contact fields) reduce traceability but do not change the substantive disclosure about the sale.

Compliance & Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 mechanics; documentation of vesting dates supports compliance with resale conditions.

The filing documents the acquisition method as net shares retained upon restricted stock vesting and lists acquisition dates and amounts, which helps demonstrate how the shares were obtained and supports compliance with Rule 144 timing and volume considerations. The broker is identified as APEX CLEARING, and no prior sales in the last three months are reported for the selling person, which is relevant for volume calculations under resale rules. From a governance perspective, this is a routine compliance filing rather than a material corporate event. Minor missing administrative fields should be corrected for full record completeness.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST SUITE 300 DALLAS TX 75201	9217	274956.00	30109078	08/25/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			1599	08/25/2025	N/A
Common	02/15/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			897	08/25/2025	N/A
Common	02/27/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			3	08/25/2025	N/A
Common	03/01/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			831	08/25/2025	N/A
Common	04/01/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			737	08/25/2025	N/A
Common	05/22/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			19	08/25/2025	N/A
Common	08/21/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			20	08/25/2025	N/A
Common	08/24/2025	Net Shares from Restricted Stock Vesting	Amalgamated Financial Corp.			5111	08/25/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Amalgamated Financial (AMAL) disclose?

The filing discloses a proposed sale of 9,217 common shares through APEX CLEARING on Nasdaq on 08/25/2025 with an aggregate market value of $274,956.

Where did the shares in the AMAL Form 144 come from?

The shares were acquired as net shares from restricted stock vesting on eight dates in 2025, totaling 9,217 shares.

How material is the proposed sale relative to AMAL's outstanding shares?

The filing lists 30,109,078 shares outstanding, so the 9,217-share block represents about 0.03% of outstanding shares, indicating limited market impact.

Were any shares sold by the reporting person in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the Form 144 include an attestation about material nonpublic information?

Yes. The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Who is the executing broker for the proposed sale in the AMAL filing?

The broker named in the filing is APEX CLEARING, 350 N St. Paul St, Suite 300, Dallas, TX 75201.